Jessica Kendrick, MD, MPH, discusses phase 3 PATH data showing upacicalcet reduced iPTH in hemodialysis patients with secondary hyperparathyroidism.
Jessica Kendrick, MD, MPH
Advertisement
Jessica Kendrick, MD, MPH, is a Professor of Medicine-Renal Med Diseases/Hypertension at University of Colorado Anschutz.
Articles by Jessica Kendrick, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
2
Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD
3
Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD
4
AD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women
5